The UK’s largest medical cannabis company has announced a new capital raise and the completion of an internal restructure. This new raise will support Lyphe Group to become cash flow…
Author
Volteface Team
-
-
Advocacy NewsFeaturedIndustry News
New UK Based Digital Study on Rare Childhood Epilepsies and Medical Cannabis
The potential of cannabis medicines to treat symptoms of epilepsy, especially for children who are resistant to other available drugs, has been one of the driving forces behind the liberalisation…
-
DM for Details: Selling Drugs in the Age of Social Media You can download the full report here Executive Summary Introduction In this report, Volteface aims to bridge the gap in…